Skin Replacement Market: By Graft Type (Auto-grafts, Allografts, Xenografts, and Synthetic Skin), By Indication Type (Burns, Ulcers, and Others), By End User (Hospitals, Dermal Wound Clinics, and Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Skin Replacement Market size was valued at USD 973.22 million in 2022 and is poised to grow at a CAGR of 5.9% from 2023-2029. The increased prevalence of dermatological illnesses is a primary driver of the skin replacement market's demand. Another major element driving the skin replacement market share is the growing number of burn victims. According to World Health Organization studies, most of the 180,000 global deaths attributable to burn injuries each year occur in low and middle-income nations. Globally increasing life expectancy rate and advancement in skin replacement technology and increasing spending on healthcare is expected to be the key growth driver for the skin replacement market during the study period. The development of artificial skin replacement goods has made significant progress. Continued research indicates that the market for skin replacement products will grow, and each new product appears to carve out its position in the field. Increased life expectancy, rising disposable income, and favorable demographics contribute to the worldwide skin replacement market's rise. Over the projected period, the worldwide skin replacement market is expected to benefit from an increase in approvals for novel skin treatment procedures. Furthermore, prominent players' increased focus on research and development operations is expected to boost market expansion in the future. Based on graft type, the auto-grafts segment accounted for the largest market share in 2021, and the market for the same segment is anticipated to grow faster at the highest rate during the forecast period. The market growth for the auto-grafts segment can be attributed to the wide use of autografts for treating open burns and wounds.

Skin Replacement Market Key Developments:
  • In Feb 2022  AVITA Medical, Inc. a regenerative medicine company announced that the United States Food and Drug Administration (FDA) has reviewed and approved the premarket approval application (PMA) supplement for RECELL Autologous Cell Harvesting Device, an enhanced RECELL System aimed at providing clinicians a more efficient user experience and simplified workflow. The RECELL System is a device that enables healthcare professionals to produce a suspension of Spray-On Skin Cells using a small sample of the patient's own skin for the treatment of acute thermal burns.  
  • In April 2021, MedSkin Solutions Dr. Suwelack AG expanded its MatriDerm portfolio with the launch of MatriDerm Flex Dermal Matrix and MatriDermFenestrated Dermal Matrix. MatriDerm is a single-use three-dimensional acellular dermal matrix composed of bovine collagen fibers and bovine elastin.

Skin Replacement Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

North America

Fastest Growing Market

North America
Skin Replacement Market Dynamics

A rise in global life expectancy, developments in skin replacement technology, and increasing healthcare spending are predicted to be the key growth drivers for the skin replacement market during the study period. However, the market would be hampered by some other factors. Lack of clinical support, the high cost of skin replacement therapy, and the lack of skilled professionals may restrain the growth of the skin replacement market over the forecast timeframe.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Skin Replacement Market Segmentation

By Graft Type
  • Autografts
  • Allografts
  • Xenografts
  • Synthetic Skin
By Indication Type
  • Burns
  • Ulcers
  • Others
By End User
  • Hospitals
  • Dermal and Wound Care Clinics
  • Others

Frequently Asked Questions

The skin replacement market is projected to expand at a CAGR of 5.9% during the forecast period

Upside Biotechnologies, Kinetics Concepts, Inc, Humeca BV, Smith and Nephew plc, Avita Medical Limited, MiMedx Group, Inc, Mallinckrodt Plc, MedSkin Solutions Dr. Suwelack AG, Organogenesis Inc, Vericel Corporation.

North-America is the fastest-growing region for skin replacement market

1.Executive Summary
2.Global Skin Replacement Market Introduction 
2.1.Global Skin Replacement Market  - Taxonomy
2.2.Global Skin Replacement Market  - Definitions
2.2.1.Graft Type
2.2.2.Indication Type
2.2.3.End User
2.2.4.Region
3.Global Skin Replacement Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Skin Replacement Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Skin Replacement Market  By Graft Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Autografts
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Allografts
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Xenografts
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Synthetic Skin
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Skin Replacement Market  By Indication Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Burns
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Ulcers
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Skin Replacement Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Dermal and Wound Care Clinics
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Skin Replacement Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Skin Replacement Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Graft Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Autografts
9.1.2.Allografts
9.1.3.Xenografts
9.1.4.Synthetic Skin
9.2.  Indication Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Burns
9.2.2.Ulcers
9.2.3.Others
9.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Dermal and Wound Care Clinics
9.3.3.Others
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Skin Replacement Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Graft Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Autografts
10.1.2.Allografts
10.1.3.Xenografts
10.1.4.Synthetic Skin
10.2.  Indication Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Burns
10.2.2.Ulcers
10.2.3.Others
10.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Dermal and Wound Care Clinics
10.3.3.Others
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Skin Replacement Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Graft Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Autografts
11.1.2.Allografts
11.1.3.Xenografts
11.1.4.Synthetic Skin
11.2.  Indication Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Burns
11.2.2.Ulcers
11.2.3.Others
11.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Dermal and Wound Care Clinics
11.3.3.Others
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Skin Replacement Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Graft Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Autografts
12.1.2.Allografts
12.1.3.Xenografts
12.1.4.Synthetic Skin
12.2.  Indication Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Burns
12.2.2.Ulcers
12.2.3.Others
12.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Dermal and Wound Care Clinics
12.3.3.Others
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Skin Replacement Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Graft Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Autografts
13.1.2.Allografts
13.1.3.Xenografts
13.1.4.Synthetic Skin
13.2.  Indication Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Burns
13.2.2.Ulcers
13.2.3.Others
13.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Dermal and Wound Care Clinics
13.3.3.Others
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Upside Biotechnologies
14.2.2.Kinetics Concepts, Inc
14.2.3.Humeca BV
14.2.4.Smith and Nephew plc
14.2.5.Avita Medical Limited
14.2.6.MiMedx Group, Inc
14.2.7.Mallinckrodt Plc
14.2.8.MedSkin Solutions Dr. Suwelack AG
14.2.9.Organogenesis Inc.
14.2.10.Vericel Corporation.
15. Research Methodology 
16. Appendix and Abbreviations 
  • Upside Biotechnologies
  • Kinetics Concepts, Inc
  • Humeca BV
  • Smith and Nephew plc
  • Avita Medical Limited
  • MiMedx Group, Inc
  • Mallinckrodt Plc
  • MedSkin Solutions Dr. Suwelack AG
  • Organogenesis Inc.
  • Vericel Corporation.

Adjacent Markets